Equities analysts expect TriMas Co. (NASDAQ:TRS) to report earnings per share of $0.46 for the current fiscal quarter, Zacks Investment Research reports. Six analysts have provided estimates for TriMas’ earnings, with estimates ranging from $0.44 to $0.47. TriMas posted earnings per share of $0.40 during the same quarter last year, which would indicate a positive year-over-year growth rate of 15%. The company is scheduled to report its next quarterly earnings results on Thursday, July 26th.
On average, analysts expect that TriMas will report full-year earnings of $1.66 per share for the current fiscal year, with EPS estimates ranging from $1.55 to $1.75. For the next fiscal year, analysts anticipate that the firm will post earnings of $1.81 per share, with EPS estimates ranging from $1.65 to $1.90. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that follow TriMas.
TriMas (NASDAQ:TRS) last released its quarterly earnings data on Thursday, April 26th. The industrial products company reported $0.41 EPS for the quarter, topping the Zacks’ consensus estimate of $0.38 by $0.03. TriMas had a net margin of 5.78% and a return on equity of 12.71%. The firm had revenue of $217.10 million during the quarter, compared to analysts’ expectations of $208.81 million. During the same period in the previous year, the business posted $0.30 earnings per share. The company’s revenue for the quarter was up 8.6% compared to the same quarter last year.
TRS has been the subject of a number of research reports. JPMorgan Chase reissued an “overweight” rating and set a $32.00 target price (down previously from $33.00) on shares of TriMas in a report on Tuesday, March 6th. BidaskClub raised TriMas from a “sell” rating to a “hold” rating in a report on Thursday, March 1st. BMO Capital Markets initiated coverage on TriMas in a report on Tuesday, April 3rd. They set an “outperform” rating and a $33.00 target price for the company. Deutsche Bank set a $29.00 target price on TriMas and gave the stock a “hold” rating in a report on Friday, January 19th. Finally, ValuEngine raised TriMas from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. TriMas currently has a consensus rating of “Buy” and an average target price of $29.33.
Shares of TRS traded down $0.10 during midday trading on Friday, reaching $28.40. 73,592 shares of the stock were exchanged, compared to its average volume of 136,881. TriMas has a twelve month low of $28.30 and a twelve month high of $28.65. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.50 and a current ratio of 2.83. The company has a market capitalization of $1.30 billion, a P/E ratio of 20.29, a P/E/G ratio of 3.34 and a beta of 1.78.
In related news, CAO Paul Swart sold 2,000 shares of the business’s stock in a transaction dated Wednesday, May 2nd. The stock was sold at an average price of $27.05, for a total value of $54,100.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Joshua A. Sherbin sold 29,546 shares of the business’s stock in a transaction dated Monday, April 30th. The shares were sold at an average price of $27.37, for a total value of $808,674.02. The disclosure for this sale can be found here. Insiders have sold 37,000 shares of company stock valued at $1,011,509 in the last three months. Insiders own 1.10% of the company’s stock.
A number of hedge funds have recently bought and sold shares of the stock. SG Americas Securities LLC acquired a new position in TriMas during the first quarter worth about $181,000. First Quadrant L P CA acquired a new position in TriMas during the fourth quarter worth about $195,000. We Are One Seven LLC acquired a new position in TriMas during the fourth quarter worth about $211,000. Cigna Investments Inc. New acquired a new position in TriMas during the fourth quarter worth about $212,000. Finally, Campbell & CO Investment Adviser LLC acquired a new position in TriMas during the first quarter worth about $222,000. 98.71% of the stock is owned by institutional investors and hedge funds.
TriMas Company Profile
TriMas Corporation manufactures and sells products for consumer products, aerospace, industrial, petrochemical, refinery, and oil and gas markets worldwide. The company operates through four segments: Packaging, Aerospace, Energy, and Engineered Components. The Packaging segment designs and manufactures industrial closure products, including steel drum and plastic enclosures, plastic drum closures, and plastic pail dispensers and plugs; and specialty dispensing products, such as foamers, lotion pumps, fine mist sprayers, and other packaging solutions for the cosmetic, personal care, and household product markets, as well as specialty plastic closures for bottles and jars, and dispensing pumps for the food and beverage markets.
Get a free copy of the Zacks research report on TriMas (TRS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.